Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Invasive Breast Cancer × atezolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 12 Carcinoma, Hepatocellular 11 Colorectal Neoplasms 10 Urinary Bladder Neoplasms 8 Small Cell Lung Carcinoma 8 Breast Neoplasms 8 Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Transitional Cell 7 Stomach Neoplasms 6 Triple Negative Breast Neoplasms 5 Melanoma 5 Glioblastoma 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Turcot syndrome 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Glioma 2 Extensive Stage Small Cell Lung Cancer 2 Carcinoma, Neuroendocrine 2 Carcinoma, Merkel Cell 2

Interventions

Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Trastuzumab 1 Radiotherapy 1 Indocyanine Green 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡